Journal
CARBOHYDRATE POLYMERS
Volume 265, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.carbpol.2021.118065
Keywords
Hydrogel; Hemostasis; Anti-inflammatory; Multiple primary tumor; Recurrence
Categories
Funding
- Villum Fonden, Denmark [13153]
Ask authors/readers for more resources
A novel therapeutic nanocomposite was developed for wound bacterial infections and tumor recurrence, utilizing released reactive oxygen species to kill bacteria and inhibit tumor cell regeneration, as well as utilizing photothermal properties to penetrate the blood tumor barrier for brain tumor treatment. The combination of the nanocomposite with immunotherapy showed potential for improving postoperative therapy and multi-tumor treatments.
Wound bacterial infections and tumor recurrence are the main reasons for the poor prognosis after primary tumor resection. Here, we fabricated a novel therapeutic nanocomposite using chitosan (CS) hydrogel combined with black phosphate nanosheets (BPNSs) and in situ grown copper nanoparticles (CuNPs). The obtained hydrogel (CS@BPNSs@CuNPs), possessing a remarkable temperature-sensitive spongy-like state, offered 24.98 % blood clotting index. The released BPNSs@CuNPs could produce reactive oxygen species (ROS) to kill infected invasive bacteria (98.1 %) and inhibit local residual tumor cell regeneration (11.3 %). Moreover, by coupling the photothermal properties of BPNSs, the BPNSs@CuNPs showed 19.6 % penetration rate to cross the blood tumor barrier (BTB) for treating brain tumors. The hydrogel platform was further combined with aPD-L1-based immunotherapy to employ its synergetic therapeutic effect in the prevention of tumors. The in vivo studies showed that biodegradable hydrogel could hold a great potential as a novel strategy for improving postoperative therapy and multi-tumor treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available